Graph Therapeutics
Austria - KlosterneuburgBiotechnology
Focus: Graph Therapeutics is an AI-driven drug discovery platform company headquartered in Austria, focused on immunology therapeutics. The company is publicly traded and leverages computational approaches to identify novel drug candidates.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Graph Therapeutics?
AI assessmentBest suited for scientists willing to join a pre-revenue AI biotech at ground level; career growth will depend heavily on platform validation and funding trajectory.
Why Work Here
- Early-stage public biotech with AI/computational drug discovery platform—ideal for scientists seeking cutting-edge technology exposure
- Focused immunology pipeline offers deep therapeutic expertise in a high-demand area
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Graph Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.